TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
TARA

Protara Therapeutics Inc

Healthcare · Biotechnology

3.60$ -4.1% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

Protara Therapeutics Inc (TARA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 209 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet TARA
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
85 68 44 44 24 7.0 203 173 113 79 181 209
85 67 43 43 23 7.0 169 93 86 69 172 160
69 40 36 21 19 6.2 169 36 24 40 163 50
84 65 41 42 22 6.2 169 91 84 66 170 156
0.7 0.6 0.5 0.2 1.3
1.2 1.2
0.1 0.2 0.4 0.3 0.3 0.5 1.2 8.9 7.9
30 30 0.0
30 30 0.1 2.7 3.2 2.9
2.3 4.1 5.1 9.2 3.1 0.6 3.9 11 11 11 14 13
2.3 4.1 5.1 9.2 3.1 0.6 2.9 4.3 5.7 6.1 11 11
0.0 0.1 0.9 0.9 1.0 1.1 1.2
0.9 1.0 0.6 0.0 0.4 0.7 0.9 1.0 1.6 2.4 4.4 3.5
82 63 38 35 20 6.4 199 162 102 68 167 196
-110 -131 -160 -190 -210 -225 -47 -94 -160 -200 -245 -302
0.3 0.4 0.4 0.4 2.6 4.1 7.2 11 11 11 21 43

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?